J&J: raises outlook after earnings beat
(CercleFinance.com) - Johnson & Johnson reported lower revenue and profit for the second quarter, mainly due to the negative impact of the Covid-19 pandemic.
Overall, J&J's quarterly sales dropped 10.8% year-on-year to 18.3 billion dollars.
The US healthcare giant announced net profit of 3.6 billion dollars, or 1.36 dollar a share, compared with 5.6 billion dollars, or 2.08 dollar a share, in the same period last year.
Analysts were expecting less, with EPS about 1.16 dollar.
J&J has raised its full-year earnings forecast, now expecting adjusted EPS of 7.75 dollars to 7.95 dollars for 2020, compared with a previous guidance of 7.50 dollars to 7.90 dollars.
Copyright (c) 2020 CercleFinance.com. All rights reserved.